HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Special blood storage could cut transfusions for cancer patients
Disease control OngoingThis study tests whether red blood cells stored with less oxygen (hypoxic RBCs) are safer and more effective than standard transfusions for people with blood cancers who need regular blood. About 24 adults with transfusion-dependent blood cancers will receive both types of blood …
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could dropping one drug make stem cell transplants safer?
Disease control OngoingThis study looks at whether it is safe to remove one immune-suppressing drug, mycophenolate mofetil (MMF), from the standard treatment plan after a stem cell transplant for blood cancers. Sixty adults aged 18 to 75 will receive the transplant without MMF and be monitored for up t…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a lower dose of cyclophosphamide make stem cell transplants less risky?
Disease control OngoingThis study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can reduce side effects while still preventing the donor cells from attacking the recipient's body. The trial includes 105 people aged 15-65 with blood cancers like leukemia or…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
NIH launches massive sample collection to unlock disease secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood, bone marrow, urine, and tissue samples from up to 6,000 people with solid tumors, blood cancers, or non-cancerous blood disorders, as well as from their healthy family members who are stem cell donors. The samples are stored and used in research to bett…
Matched conditions: HEMATOLOGIC NEOPLASMS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC